58 documents as of September 2nd, 2020

MDCG work in progress

Ongoing guidance documents

MDCG 2018-1 Rev.4Guidance on basic UDI-DI and changes to UDI-DIApril 2021
MDCG 2020-18MDCG Position Paper on UDI assignment for Spectacle lenses & Ready readersDecember 2020
MDCG 2018-3 Rev.1Guidance on UDI for systems and procedure packsJune 2020
MDCG 2018-1 v3Guidance on basic UDI-DI and changes to UDI-DIMarch 2020
MDCG 2019-1MDCG guiding principles for issuing entities rules on basic UDI-DIJanuary 2019
MDCG 2019-2Guidance on application of UDI rules to device-part of products referred to in article 1(8), 1(9) and 1(10) of Regulation 745/2017February 2019
MDCG 2018-2Future EU medical device nomenclature – Description of requirementsMarch 2018
MDCG 2018-4Definitions/descriptions and formats of the UDI core elements for systems or procedure packsOctober 2018
MDCG 2018-5UDI assignment to medical device softwareOctober 2018
MDCG 2018-6Clarifications of UDI related responsibilities in relation to article 16October 2018
MDCG 2018-7Provisional considerations regarding language issues associated with the UDI databaseOctober 2018
MDCG 2020-15MDCG Position Paper on the use of the EUDAMED actor registration module and of the Single Registration Number (SRN) in the Member StatesAugust 2020
2019-4Timelines for registration of device data elements in EUDAMEDApril 2019
2019-5Registration of legacy devices in EUDAMEDApril 2019
European Medical Device Nomenclature (EMDN)
The EMDN – The nomenclature of use in EUDAMEDJanuary 2020
The CND nomenclature – Background and general principlesJanuary 2020
Notified bodies
MDCG 2020-17Questions and Answers related to MDCG 2020-4:
“Guidance on temporary extraordinary measures related to medical device notified body audits during COVID-19 quarantine orders and travel restrictions”
December 2020
MDCG 2020-14Guidance for notified bodies on the use of MDSAP audit reports in the context of surveillance audits carried out under the Medical Devices Regulation (MDR)/In Vitro Diagnostic medical devices Regulation (IVDR)August 2020
MDCG 2020-12Guidance on transitional provisions for consultations of authorities on devices incorporating a substance which may be considered a medicinal product and which has action ancillary to that of the device, as well as on devices manufactured using TSE susceptible animal tissuesJune 2020
MDCG 2020-11Guidance on the renewal of designation and monitoring of notified bodies under Directives 90/385/EEC and 93/42/EEC to be performed in accordance with Commission Implementing Regulation (EU) 2020/666 amending Commission Implementing Regulation (EU) 920/2013May 2020
MDCG 2020-4Guidance on temporary extraordinary measures related to medical device notified body audits during COVID-19 quarantine orders and travel restrictionsApril 2020
MDCG 2020-3Guidance on significant changes regarding the transitional provision under Article 120 of the MDR with regard to devices covered by certificates according to MDD or AIMDDMarch 2020
MDCG 2019-14Explanatory note on MDR codesDecember 2019
MDCG 2019-13Guidance on sampling of devices for the assessment of the technical documentationDecember 2019
MDCG 2019-12Designating authority’s final assessment form: Key information (EN)October 2019
MDCG 2019-10Application of transitional provisions concerning validity of certificates issued in accordance to the directivesOctober 2019
MDCG 2019-6 v2Questions and answers: Requirements relating to notified bodiesOcotober2019
MDCG 2018-8Guidance on content of the certificates, voluntary certificate transfersNovember 2018
NBOG BPG 2017-1Best practice guidance on designation and notification of conformity assessment bodiesFebruary 2018
NBOG BPG 2017-2Best practice guidance on the information required for personnel involved in conformity assessment  February 2018
NBOG F 2017-1Application form to be submitted by a conformity assessment body when applying for designation as notified body under the medical devices regulation (MDR)  February 2018
NBOG F 2017-2Application form to be submitted by a conformity assessment body when applying for designation as a notified body under the in vitro diagnostic devices regulation (IVDR)February 2018
NBOG F 2017-3Applied-for scope of designation and notification of a conformity assessment body – Regulation (EU) 2017/745 (MDR)February 2018
NBOG F 2017-4Applied-for scope of designation and notification of a conformity assessment body – Regulation (EU) 2017/746 (IVDR)February 2018
NBOG F 2017-5Preliminary assessment review template (MDR)February 2018
NBOG F 2017-6Preliminary assessment review template (IVDR)February 2018
NBOG F 2017-7Review of qualification for the authorisation of personnel (MDR)February 2018
NBOG F 2017-8Review of qualification for the authorisation of personnel (IVDR)February 2018
Clinical investigation and evaluation
MDCG 2020-13
Word version
Clinical evaluation assessment report templateJuly 2020
MDCG 2020-10/1
MDCG 2020-10/2
Guidance on safety reporting in clinical investigations
Appendix: Clinical investigation summary safety report form
May 2020
May 2020
MDCG 2020-8Guidance on PMCF evaluation report templateApril 2020
MDCG 2020-7Guidance on PMCF plan templateApril 2020
MDCG 2020-6Guidance on sufficient clinical evidence for legacy devicesApril 2020
MDCG 2020-5Guidance on clinical evaluation – EquivalenceApril 2020
MDCG 2019-9Summary of safety and clinical performanceAugust 2019
New technologies
MDCG 2020-1Guidance on clinical evaluation (MDR) / Performance evaluation (IVDR) of medical device softwareMarch 2020
MDCG 2019-16 rev.1Guidance on cybersecurity for medical devicesDecember 2019
MDCG 2019-11Qualification and classification of software – Regulation (EU) 2017/745 and Regulation (EU) 2017/746October 2019
Other topics
MDCG 2020-16Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746November 2020
MDCG 2020-9Regulatory requirements for ventilators and related accessoriesApril 2020
MDCG 2019-3 rev.1Interpretation of article 54(2)bApril 2020
MDCG 2020-2 rev.1Class I transitional provisions under Article 120 (3 and 4) – (MDR)March 2020
MDCG 2019-8 v2Guidance document implant card on the application of Article 18 Regulation (EU) 2017/745 on medical devicesMarch 2020
MDCG 2019-15 rev.1Guidance notes for manufacturers of class I medical devicesDecember 2019
MDCG 2019-7Guidance on article 15 of the medical device regulation (MDR) and in vitro diagnostic device regulation (IVDR) on a ‘person responsible for regulatory compliance’ (PRRC)June 2019

Commission Guidance Documents

Conformity assessment procedures for protective equipmentJuly 2020
How to verify that medical devices and personal protective equipment can be lawfully placed on the EU market and thus purchased and used – also in the COVID-19 contextMay 2020
Guidance on regulatory requirements for medical face masksJune 2020
Guidance on medical devices, active implantable medical devices and in vitro diagnostic medical devices in the COVID-19 contextApril 2020
Conformity assessment procedures for 3D printing and 3D printed products to be used in a medical context for COVID-19April 2020

Other guidance documents

SCHEER guidelinesGuidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices
covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
June 2019
CAMD FAQCAMD MDR/IVDR Transition Subgroup: FAQ – MDR Transitional provisionsJanuary 2018